O7 Remedy, an Egyptian e-health agency, has raised $2.1 million in a seed spherical

O7 Remedy, an Egyptian e-health enterprise, has raised a seed spherical of $2.1 million to assist it develop throughout the Center East and provide further product options. 

Hikma Ventures led the seed spherical, which included C-Ventures, Lotus Ventures, and a lot of angel traders. 

O7 Remedy is a technology-enabled therapeutic platform with a community of bilingual psychiatrists and psychotherapists to assist purchasers via psychological well being difficulties. It was based in 2019 by Ashraf Bacheet, Ashraf Adel, and Nader Iskander. 

“Everybody deserves simple, customized, and reliable entry to high-quality psychological wellness therapies.” “That is what motivates us to do what we do,” Bacheet defined. 

“Whereas COVID-19 has hastened the adoption of digital well being providers, it has additionally contributed to a rise in psychological well being problems like loneliness, stress, nervousness, burnout, and others.” “We consider O7 Remedy is well-positioned to resolve a few of these points and supply shoppers with a trusted platform for improved well being and wellbeing,” Hamzeh Abdul-Hadi, principal at Hikma Ventures, mentioned. 

The brand new funding will assist O7 Remedy develop all through the Center East, in addition to permit for the event of recent product options and enhancements. 

It can additionally allow the group to develop its Company Wellness Applications to incorporate extra corporations within the area.


Learn extra on Tech Gist Africa:

Gaviti raises $9 million in a Sequence A funding spherical

Tremendous app for Egyptian monetary providers Fortunate has secured a $25 million Sequence A spherical of funding

FlapKap, an Egyptian SaaS platform, has acquired $1.2 million in funding

The submit O7 Remedy, an Egyptian e-health agency, has raised $2.1 million in a seed spherical appeared first on Techgist Africa | Africa Main Tech Information, Critiques and Suggestions.


Leave A Reply

Your email address will not be published.